MARKET

VSTM

VSTM

Verastem
NASDAQ
11.30
-0.51
-4.32%
After Hours: 11.01 -0.29 -2.57% 17:50 04/12 EDT
OPEN
11.76
PREV CLOSE
11.81
HIGH
11.77
LOW
11.10
VOLUME
85.31K
TURNOVER
0
52 WEEK HIGH
15.18
52 WEEK LOW
4.260
MARKET CAP
285.84M
P/E (TTM)
-2.8525
1D
5D
1M
3M
1Y
5Y
Analysts Offer Insights on Healthcare Companies: Shattuck Labs (STTK) and Verastem (VSTM)
TipRanks · 1d ago
Verastem Releases Updated Corporate Presentation for Investors
TipRanks · 4d ago
Weekly Report: what happened at VSTM last week (0401-0405)?
Weekly Report · 5d ago
VERASTEM ONCOLOGY ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 04/04 11:30
Weekly Report: what happened at VSTM last week (0325-0329)?
Weekly Report · 04/01 11:46
Catalyst Watch: Tesla deliveries, Disney board vote, DJT drama and Fortinet event
Volatility watch - Options trading volume is elevated on Trump Media & Technology (DJT) Key data reports due to arrive this week include updates on Tesla deliveries, Disney board vote, and Solventum spin-off. Fortinet will hold its four-day Accelerate 2024 event in New York.
Seeking Alpha · 03/28 19:00
Verastem’s Strategic Advancements and Financial Stability Underscore Buy Rating
TipRanks · 03/27 07:15
Weekly Report: what happened at VSTM last week (0318-0322)?
Weekly Report · 03/25 11:49
More
About VSTM
Verastem, Inc. is a late-stage development biopharmaceutical company. The Company's pipeline is focused on anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) inhibition and focal adhesion kinase (FAK) inhibition. The Company’s advanced product candidates, avutometinib and defactinib, are being investigated in both preclinical and clinical studies for the treatment of various solid tumors, including low-grade serous ovarian cancer (LGSOC), non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer (CRC), and melanoma. Avutometinib is an orally available small molecule RAF/MEK clamp that inhibits the ras sarcoma (RAS)/RAF/MEK, ERK mitogen activated pathway kinase (MAPK) pathway. Defactinib is an oral small molecule inhibitor of FAK and proline-rich tyrosine kinase (PYK2).

Webull offers Verastem Inc stock information, including NASDAQ: VSTM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VSTM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VSTM stock methods without spending real money on the virtual paper trading platform.